Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$513M |
| 2 |
Medtronic
MDT
|
+$477M |
| 3 |
Apple
AAPL
|
+$403M |
| 4 |
L3Harris
LHX
|
+$334M |
| 5 |
Danaher
DHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$433M |
| 2 |
AbbVie
ABBV
|
+$350M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
+$315M |
| 4 |
CoStar Group
CSGP
|
+$273M |
| 5 |
Abbott
ABT
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Mondelez International
MDLZ
$77.9B
| $53.9M | 0.03% |
974,029
+435,068
| +81% | +$23.8M |
|
552
Kohl's
KSS
$2.1B
| $53.8M | 0.03% |
1,083,625
-907,069
| -46% | -$44.5M |
|
553
Yum China
YUMC
$15.3B
| $53.7M | 0.03% |
1,182,771
+99,201
| +9% | +$4.43M |
|
554
Paylocity
PCTY
$6.97B
| $53.7M | 0.03% |
550,712
+98,423
| +22% | +$10.1M |
|
555
J&J Snack Foods
JJSF
$1.46B
| $53.7M | 0.03% |
279,514
+513
| +0.2% | +$93.1K |
|
556
Valvoline
VVV
$5.05B
| $53.6M | 0.03% |
2,431,082
+261,075
| +12% | +$5.6M |
|
557
Arch Capital
ACGL
$36.3B
| $53.4M | 0.03% |
1,272,813
+144,935
| +13% | +$5.71M |
|
558
Avery Dennison
AVY
$12.5B
| $53.3M | 0.03% |
469,058
+189,361
| +68% | +$21.6M |
|
|
GWPH
559
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $53.3M | 0.03% |
463,016
-548
| -0.1% | -$83.2K |
|
|
XLRN
560
DELISTED
Acceleron Pharma
XLRN
| $53.2M | 0.03% |
1,345,405
+35,736
| +3% | +$1.55M |
|
561
IDEX
IEX
$16.6B
| $52.5M | 0.03% |
320,331
+48,378
| +18% | +$8.03M |
|
|
IMMU
562
DELISTED
Immunomedics Inc
IMMU
| $52.3M | 0.03% |
3,944,509
-11,780
| -0.3% | -$173K |
|
|
ABMD
563
DELISTED
Abiomed Inc
ABMD
| $52.2M | 0.03% |
293,591
-263,098
| -47% | -$56.9M |
|
564
Rollins
ROL
$18.8B
| $52.1M | 0.03% |
2,295,840
-723,872
| -24% | -$16.6M |
|
565
Enanta Pharmaceuticals
ENTA
$370M
| $52M | 0.03% |
865,309
-79,478
| -8% | -$5.9M |
|
566
Hancock Whitney
HWC
$6.07B
| $51.9M | 0.03% |
1,356,009
+175,750
| +15% | +$6.68M |
|
567
WSFS Financial
WSFS
$4.14B
| $51.6M | 0.03% |
1,170,575
+337,674
| +41% | +$14.2M |
|
|
DRE
568
DELISTED
Duke Realty Corp.
DRE
| $51.2M | 0.03% |
1,507,849
+373,139
| +33% | +$12.4M |
|
569
Equifax
EFX
$20.8B
| $51.1M | 0.03% |
363,018
+138,017
| +61% | +$19.4M |
|
570
Trex
TREX
$4.57B
| $51M | 0.03% |
1,122,532
+2,220
| +0.2% | +$89.5K |
|
|
INST
571
DELISTED
Instructure, Inc.
INST
| $51M | 0.03% |
1,316,204
-2,558
| -0.2% | -$104K |
|
572
Edison International
EIX
$30.3B
| $50.9M | 0.03% |
674,351
-215,340
| -24% | -$15.5M |
|
573
Omnicell
OMCL
$1.89B
| $50.6M | 0.03% |
700,745
+2,007
| +0.3% | +$147K |
|
574
Willis Towers Watson
WTW
$28.6B
| $50.5M | 0.03% |
261,844
+145,533
| +125% | +$28.4M |
|
|
CARO
575
DELISTED
Carolina Financial Corp.
CARO
| $50.5M | 0.03% |
1,421,258
+90,985
| +7% | +$3.17M |
|
Similar funds
Janus Henderson Group's Q3 2019 Portfolio in Review
As of Q3 2019, Janus Henderson Group held 1,465 positions worth $185B, up 0.14% from $184B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q3 2019 filing shows 95 new, 675 increased, 602 reduced and 67 closed positions. Its largest new stake was Medtronic: 4,571,875 shares worth $497M. The largest sale was Mastercard, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2019 buy was Medtronic: 4,571,875 shares worth $497M.
- Janus Henderson Group added most to Fidelity National Information Services in Q3 2019, an estimated $513M increase.
- Janus Henderson Group's biggest Q3 2019 reduction was Mastercard, cutting an estimated $433M.
- Janus Henderson Group fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $315M.
- Janus Henderson Group's ten largest holdings make up 17% of its $185B portfolio in Q3 2019.
- Janus Henderson Group opened 95 new positions and closed 67 in Q3 2019.
- Janus Henderson Group's portfolio value rose 0.14% quarter-over-quarter to $185B.
Based on Janus Henderson Group's 13F filing for Q3 2019, filed 14 Nov 2019.